Document is current

Any future updates will be listed below

Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy

Crossref DOI link: https://doi.org/10.1007/978-1-0716-0771-8_5

Published Online: 2020-09-01

Published Print: 2020

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark